Intrinsic Value

Is NTK1 undervalued or overvalued?

See the intrinsic value estimate for EMV Capital PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

NTK1 Intrinsic Value
LOCKED
Unlock
Today vs. history

NTK1 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with NTK1’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor NTK1
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price €0.47
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NTK1

Fundamental Analysis

What EMV Capital Does

Health Care

EMV Capital PLC is a London-listed venture capital and growth investor that puts money and support into early-stage technology and life sciences companies. It backs businesses in areas such as healthcare, clean technology, and industrial technology, usually when they are still too small or too specialized for mainstream public markets or traditional lenders.

Headquarters
United Kingdom UK
Employees
24
IPO date
Sep 16, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
EMV Capital PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one NTK1 stock?

The intrinsic value for EMV Capital PLC (NTK1) under the Base Case is hidden EUR.

Is NTK1 stock undervalued or overvalued?

Compared with the current market price of 0.468 EUR, the stock appears hidden.

Back to Top